Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Rapid Micro Biosystems (RPID) Interest Expenses (2020 - 2025)

Rapid Micro Biosystems (RPID) has disclosed Interest Expenses for 5 consecutive years, with $673000.0 as the latest value for Q4 2025.

  • Quarterly Interest Expenses rose 5508.33% to $673000.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $1.1 million through Dec 2025, up 4534.78% year-over-year, with the annual reading at $1.1 million for FY2025, 2625.0% up from the prior year.
  • Interest Expenses hit $673000.0 in Q4 2025 for Rapid Micro Biosystems, up from $393000.0 in the prior quarter.
  • In the past five years, Interest Expenses ranged from a high of $932000.0 in Q1 2021 to a low of $10000.0 in Q2 2022.
  • Historically, Interest Expenses has averaged $376000.0 across 4 years, with a median of $206000.0 in 2021.
  • Biggest five-year swings in Interest Expenses: tumbled 98.92% in 2022 and later skyrocketed 5508.33% in 2025.
  • Year by year, Interest Expenses stood at $19000.0 in 2021, then plummeted by 47.37% to $10000.0 in 2022, then rose by 20.0% to $12000.0 in 2024, then surged by 5508.33% to $673000.0 in 2025.
  • Business Quant data shows Interest Expenses for RPID at $673000.0 in Q4 2025, $393000.0 in Q3 2025, and $12000.0 in Q4 2024.